UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH

Canadian journal of gastroenterology & hepatology, 2016-01, Vol.2016, p.6489012-7

2016

Link zum Volltext

Verfügbarkeit prüfen

Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism

Journal of hepatology, 2016-04, Vol.64 (4), p.925-932

2016

Link zum Volltext

Verfügbarkeit prüfen

Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway

Gut, 2018-12, Vol.67 (12), p.2169

2018

Link zum Volltext

Verfügbarkeit prüfen

Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds

Journal of hepatology, 2015-06, Vol.62 (6), p.1412-1419

2015

Link zum Volltext

Verfügbarkeit prüfen

Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study

Endocrine, 2017-04, Vol.56 (1), p.208-211

2017

Link zum Volltext

Verfügbarkeit prüfen

Caveolin1 protects against diet induced hepatic lipid accumulation in mice

PloS one, 2017-06, Vol.12 (6), p.e0178748-e0178748

2017

Link zum Volltext

Verfügbarkeit prüfen

Epstein-Barr virus infection and genome polymorphisms on gastric remnant carcinoma: a meta-analysis

Cancer cell international, 2020-08, Vol.20 (1), p.401-401, Article 401

2020

Link zum Volltext

Verfügbarkeit prüfen

Helicobacter pylori Induces Increased Expression of the Vitamin D Receptor in Immune Responses

Helicobacter (Cambridge, Mass.), 2014-02, Vol.19 (1), p.37-47

2014

Link zum Volltext

Verfügbarkeit prüfen

Intestinal ulcers in a patient with myelodysplastic syndrome: a case report

BMC gastroenterology, 2021-10, Vol.21 (1), p.1-372, Article 372

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease

Scientific reports, 2015-09, Vol.5 (1), p.13729-13729, Article 13729

2015

Link zum Volltext

Verfügbarkeit prüfen

Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis

Scientific reports, 2016-03, Vol.6 (1), p.23522-23522, Article 23522

2016

Link zum Volltext

Verfügbarkeit prüfen

Celastrol pretreatment attenuates concanavalin A‐induced hepatitis in mice by suppressing interleukin‐6/STAT3‐interleukin‐17 signaling

Journal of gastroenterology and hepatology, 2023-05, Vol.38 (5), p.821-829

2023

Link zum Volltext

Verfügbarkeit prüfen

PGC1α deficiency reverses cholestasis-induced liver injury via attenuating hepatic inflammation and promoting bile duct remodeling

Acta histochemica, 2023-12, Vol.125 (8), p.152097-152097, Article 152097

2023

Link zum Volltext

Verfügbarkeit prüfen

PGC1α protects against hepatic steatosis and insulin resistance via enhancing IL10‐mediated anti‐inflammatory response

The FASEB journal, 2020-08, Vol.34 (8), p.10751-10761

2020

Link zum Volltext

Verfügbarkeit prüfen

Sa2050 Screening for Pancreatic Cancer in Familial High-Risk Individuals: A Systematic Review

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-394-S-394

2015

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Helicobacter pylori Infection and its Relation with Body Mass Index in a Chinese Population

Helicobacter (Cambridge, Mass.), 2014-12, Vol.19 (6), p.437-442

2014

Link zum Volltext

Verfügbarkeit prüfen

Serum Fibroblast Growth Factor 1 is Associated with the Decreased Risk of Obesity in Human

Experimental and clinical endocrinology & diabetes, 2017-05, Vol.125 (5), p.322

2017

Link zum Volltext

Verfügbarkeit prüfen

Sa1667 Hepatic-Specific Activation of Peroxisome Proliferator-Activated Receptor Y Coactivator-1α Protected Against Steatohepatitis

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S1090-S1090

2016

Link zum Volltext

Verfügbarkeit prüfen

Mo1543 Inhibition of MPST Prevents Hepatic Steatosis Through Hydrogen Sulfide-Dependent Mechanism

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S1140-S1140

2016

Link zum Volltext

Verfügbarkeit prüfen

Peroxisome proliferator-activated receptor γ coactivator 1α maintains NAD+ bioavailability protecting against steatohepatitis

Life Medicine, 2022-10, Vol.1 (2), p.207-220

2022

Link zum Volltext

Verfügbarkeit prüfen

Su1795 Uric Acid Regulates Hepatic Steatosis and Insulin Resistance Through the NLRP3 Inflammasome Dependent Mechanism

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-1053-S-1053

2015

Link zum Volltext

Verfügbarkeit prüfen

Su1796 Xanthine Oxidase Promotes Hyperuricemia and Nonalcoholic Fatty Liver Disease in Patients and Mice

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-1053-S-1053

2015

Link zum Volltext

Verfügbarkeit prüfen

Sa1847 A Novel Candidate Tumor Suppressor: Reduced Expression of MPST Indicates Poor Prognosis of Hepatocellular Carcinoma

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-1023-S-1023

2015

Link zum Volltext

Verfügbarkeit prüfen

Computational Prediction and Validation of BAHD1 as a Novel Molecule for Ulcerative Colitis

Scientific reports, 2015-07, Vol.5, p.12227-12227

2015

Link zum Volltext

Verfügbarkeit prüfen

Computational Prediction and Validation of BAHD1 as a Novel Molecule for UlcerativeColitis

Scientific reports, 2015-07, Vol.5 (1), Article 12227

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH

Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism

Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway

Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds

Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study

Caveolin1 protects against diet induced hepatic lipid accumulation in mice

Epstein-Barr virus infection and genome polymorphisms on gastric remnant carcinoma: a meta-analysis

Helicobacter pylori Induces Increased Expression of the Vitamin D Receptor in Immune Responses

Intestinal ulcers in a patient with myelodysplastic syndrome: a case report

Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease

Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis

Celastrol pretreatment attenuates concanavalin A‐induced hepatitis in mice by suppressing interleukin‐6/STAT3‐interleukin‐17 signaling

PGC1α deficiency reverses cholestasis-induced liver injury via attenuating hepatic inflammation and promoting bile duct remodeling

PGC1α protects against hepatic steatosis and insulin resistance via enhancing IL10‐mediated anti‐inflammatory response

Sa2050 Screening for Pancreatic Cancer in Familial High-Risk Individuals: A Systematic Review

Prevalence of Helicobacter pylori Infection and its Relation with Body Mass Index in a Chinese Population

Serum Fibroblast Growth Factor 1 is Associated with the Decreased Risk of Obesity in Human

Sa1667 Hepatic-Specific Activation of Peroxisome Proliferator-Activated Receptor Y Coactivator-1α Protected Against Steatohepatitis

Mo1543 Inhibition of MPST Prevents Hepatic Steatosis Through Hydrogen Sulfide-Dependent Mechanism

Peroxisome proliferator-activated receptor γ coactivator 1α maintains NAD+ bioavailability protecting against steatohepatitis

Su1795 Uric Acid Regulates Hepatic Steatosis and Insulin Resistance Through the NLRP3 Inflammasome Dependent Mechanism

Su1796 Xanthine Oxidase Promotes Hyperuricemia and Nonalcoholic Fatty Liver Disease in Patients and Mice

Sa1847 A Novel Candidate Tumor Suppressor: Reduced Expression of MPST Indicates Poor Prognosis of Hepatocellular Carcinoma

Computational Prediction and Validation of BAHD1 as a Novel Molecule for Ulcerative Colitis

Computational Prediction and Validation of BAHD1 as a Novel Molecule for UlcerativeColitis

Suchergebnisse filtern